The results indicated that EGLN2 4-bp ins/del polymorphism was not correlated with PCa susceptibility in heterozygous (OR=0.98, 95%CI=0.61-1.57, p=0.816), homozygous (OR=0.50, 95%CI=0.21-1.21, p=0.126) dominant (OR=0.91, 95%CI= 0.58-1.45, p=0.695, recessive (OR=1.95, 95%CI=0.87-4.41, p=107) and allele (OR=0.92, 95%CI=0.69-1.25, p=0.649) genetic models. This evidence concerns the gene EGLN2 and posterior cortical atrophy.